3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Burkitt Lymphoma
19
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Leukemia
3
Recurrence
2
Neoplasm, Residual
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Blast Crisis
2
Philadelphia Chromosome
1
Lymphoma
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Lymphoid
1
Hematologic Neoplasms
1
Down Syndrome
1
Interventions
olverembatinib
1
fludarabine
1
blinatumomab
1
Prednisone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Philadelphia Chromosome
×
blinatumomab
×
Clear all
NCT06220487
2024-01-24
ABC
Nanfang Hospital, Southern Medical University
Phase 2
Recruiting
67 enrolled